1569 / 1726
Common dose planning aims for
target structures
EBRT dose BT dose
EQD2
Total EQD2
EBRT+BT
Elective lymph node target: CTV-E 45-50Gy
-
45-50Gy
Pathological lymph nodes
55-60Gy
0-4Gy
60Gy
Intermediate Risk CTV: CTV
IR
45-50Gy
15-20Gy 60-70Gy
High Risk CTV: CTV
HR
45-50Gy
35-45Gy 85-90Gy
GTV
45-50Gy
50-55Gy 95-100Gy
Point A
45-50Gy
25-40Gy 70-85Gy